UNI-EN 80:Notification - current report 80
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 80 | / | 2016 | |||||||
| Date of issue: | 2016-08-16 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification - current report 80 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 17. 1 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| In accordance with the provisions of art. 27, para 3 from Ordinance 2 on the prospectuses Sopharma AD hereby advises that the company has published and disseminated information to the public in the last 12 months in the Republic of Bulgaria and in other member states in the following ways: 1. Through the unified information system of the Bulgarian Stock Exchange E-register - www.fsc.bg; 2. Through X3news information agency - http://www.x3news.com; 3. Through the electroinc media Investor.bg - www.investor.bg; 4. Through Infostock bulletin – www.infostock.bg/; 5. Through the internet web site of the company – www.sopharma.bg; 6. Through the Polish Financial Supervision Commission system ESPI; 7. Through the Polish Press Agency – www.pap.pl Please, make the above information public. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Notification - current report 80.doc Notification - current report 80.doc | Notification - current report 80 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2016-08-16 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 5.31 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
